β-Klotho (β-Kl), a transmembrane
protein expressed in the liver, pancreas, adipose tissues, and brain, is essential for feedback suppression of hepatic
bile acid synthesis. Because
bile acid is a key regulator of
lipid and energy metabolism, we hypothesized potential and tissue-specific roles of β-Kl in regulating plasma
lipid levels and
body weight. By crossing β-kl(-/-) mice with newly developed hepatocyte-specific β-kl transgenic (Tg) mice, we generated mice expressing β-kl solely in hepatocytes (β-kl(-/-)/Tg). Gene expression, metabolomic, and in vivo flux analyses consistently revealed that plasma level of
cholesterol, which is over-excreted into feces as
bile acids in β-kl(-/-), is maintained in β-kl(-/-) mice by enhanced de novo cholesterogenesis. No compensatory increase in lipogenesis was observed, despite markedly decreased plasma
triglyceride. Along with enhanced
bile acid synthesis, these
lipid dysregulations in β-kl(-/-) were completely reversed in β-kl(-/-)/Tg mice. In contrast, reduced
body weight and resistance to diet-induced
obesity in β-kl(-/-) mice were not reversed by hepatocyte-specific restoration of β-Kl expression. We conclude that β-Kl in hepatocytes is necessary and sufficient for
lipid homeostasis, whereas nonhepatic β-Kl regulates energy metabolism. We further demonstrate that in a condition with excessive
cholesterol disposal, a robust compensatory mechanism maintains
cholesterol levels but not
triglyceride levels in mice.